Linktree’s Latest Acquisition: Koji, a Link-in-Bio Platform, Marks Its Second Investment of the Year
Australia-based link-in-bio platform Linktree announced today that it has acquired competitor Koji from its parent company GoMeta for an undisclosed amount.
The company is offering Koji users three months of Linktree Pro plan as a trial.
“We’re thrilled to welcome Koji users to the Linktree community and are excited to continue to innovate on the category we created.
The company launched Koji as a link-in-bio platform in March 2021 and raised $16 million through its parent entity.
In a previous avatar, Koji let non-technical developers make “mini apps on the web,” which were later turned into templates on the link-in-bio platform.
